Gout: A critical analysis of scientific development

Rheumatology International

Volumn 33, Issue 11, 2013, Pages 2743-2750

  Gerber, Alexander ^a   Groneberg, David A ^a   Klingelhöfer, Doris ^a   Bundschuh, Matthias ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

Bias; Gout; Scientometric analysis; Self citation

Indexed keywords

CANAKINUMAB; NONSTEROID ANTIINFLAMMATORY AGENT; PEGLOTICASE;

ARTHRITIS; ARTICLE; GOUT; HUMAN; PRIORITY JOURNAL; RHEUMATIC DISEASE;

BIBLIOMETRICS; BIOMEDICAL RESEARCH; GOUT; HUMANS; JOURNAL IMPACT FACTOR;

EID: 84886701569     PISSN: 01728172     EISSN: 1437160X     Source Type: Journal    
DOI: 10.1007/s00296-013-2805-1     Document Type: Article

References (24)

1. Andersen J, Belmont J, Cho CT (2006) Journal impact factor in the era of expanding literature. J Microbiol Immunol Infect 39:436-443
2. Bartneck C, Kokkelmans S (2011) Detecting h-index manipulation through self-citation analysis. Scientometrics 87:85-98
3. Chen LX, Schumacher HR (2008) Gout: an evidence-based review. J Clin Rheumatol 14:S55-S62
4. Choi H (2008) Primer on the rheumatic diseases: gout epidemiology, pathology and pathogenesis. Springer Science and Business Media LLC, New York, USA
5. Choi HK, Curhan G (2007) Coffee, tea, and caffeine consumption and serum uric acid level: the third national health and nutrition examination survey. Arthritis Rheum 57:816-821
6. Choi HK, Mount DB, Reginato AM (2005) Pathogenesis of gout. Ann Intern Med 143:499-516
7. Garfield E (1986) Which medical journals have the greatest impact? Ann Intern Med 105:313-320
8. Gastner MT, Newman ME (2004) From the cover: diffusion-based method for producing density-equalizing maps. Proc Natl Acad Sci USA 101:7499-7504
9. Hak AE, Choi HK (2008) Menopause, postmenopausal hormone use and serum uric acid levels in US women - the third national health and nutrition examination survey. Arthritis Res Ther 10:R116
10. Haug C (2006) Authorship and co-authorship. Tidsskr Nor Laegeforen 126:429
11. Hirsch JE (2007) Does the H index have predictive power? Proc Natl Acad Sci USA 104:19193-19198
12. Hirsch JE (2005) An index to quantify an individual's scientific research output. Proc Natl Acad Sci USA 102:16569-16572
13. Kulkarni AV, Aziz B, Shams I, et al. (2011) Author self-citation in the general medicine literature. PLoS One 6:e20885
14. Man CY, Cheung IT, Cameron PA, et al. (2007) Comparison of oral prednisolone/paracetamol and oral indomethacin/paracetamol combination therapy in the treatment of acute goutlike arthritis: a double-blind, randomized, controlled trial. Ann Emerg Med 49:670-677
15. Martinon F, Petrilli V, Mayor A, et al. (2006) Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 440:237-241
16. Mohebbi MR (2008) The impact of "Impact Factor" on medical journalism in the developing world! Indian Pediatr 45:604
17. Onuora S (2012) Crystal arthritis: canakinumab relieves gout flares when treatment options are limited. Nat Rev Rheumatol 8:369
18. Petrilli V, Martinon F (2007) The inflammasome, autoinflammatory diseases, and gout. Jt Bone Spine 74:571-576
19. Richette P, Bardin T (2010) Gout. Lancet 375:318-328
20. Saag KG, Choi H (2006) Epidemiology, risk factors, and lifestyle modifications for gout. Arthritis Res Ther 8(Suppl 1):S2
21. Sundy JS, Baraf HS, Yood RA, et al. (2011) Efficacy and tolerability of pegloticase for the treatment of chronic gout in patients refractory to conventional treatment: two randomized controlled trials. JAMA 306:711-720
22. Terkeltaub R (2010) Update on gout: new therapeutic strategies and options. Nat Rev Rheumatol 6:30-38
23. Zhang W, Doherty M, Bardin T, et al. (2006) EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 65:1312-1324
24. Zhang W, Doherty M, Pascual E, et al. (2006) EULAR evidence based recommendations for gout. Part I: Diagnosis. Report of a task force of the Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 65:1301-1311